Global Health sets the “logical date” for the launch of the Corona vaccine

0
42


With the increasing frequency of promising news about the expected vaccine for the virus

With the increasing frequency of promising news about the expected vaccine against the Corona virus, as more than one party announced that it is close to its production, the World Health Organization is still cautious in optimism about this matter that the world has been waiting for months … a warning confirmed by the Director-General of the organization, declaring that no A widely effective vaccine is expected “before the middle of next year”.

This announcement appears relatively disappointing after the increase in expectations and announcements about the provision of the vaccine before the end of the year, but there are many challenges facing the process of manufacturing a safe and effective vaccine, the most important of which are those related to ensuring the safety of its use among humans, as the vaccine may be effective among animals, but it is not It prevents infection in humans, as happened with a number of SARS vaccines.

In addition to the need to enable the vaccine to provide long-term protection for individuals, as it turns out, the Corona virus can infect the same person a few months after the first infection.

One of the other most important challenges facing the Corona vaccine is the possibility of protecting people from the older age groups, which are the most vulnerable groups in the face of the virus, which are usually the least responsive to vaccines.

In order for the vaccine to prove its effectiveness and safety, it must pass the animal testing phase first, which are tests that follow strict laboratory guidelines and usually take between three and six months.

After that, the clinical testing stage begins, which is in 3 stages, where the first stage is devoted to assessing the safety of the vaccine in terms of use in humans.

According to “Sky News” during the second stage, the vaccine composition and doses are approved in order to ensure its effectiveness.

As for the third stage, it is necessary to ensure the safety and efficacy of the vaccine on a larger group of individuals.

Steps that global laboratories are close to achieving in their battle with the Corona virus, today there are 9 vaccines around the world that have entered the final stage of testing, while the world remains waiting.

As for the most prominent vaccines that are currently being worked on, we review them as follows:

Russian vaccine

Researchers say that “Sputnik-V” gives initial encouraging results .. It made an immune response and did not leave side effects.

Chinese vaccine

“Sinopharma” will be ready for public use by the end of 2020, according to company statements, and it will be available at a cost of $ 144 for the two doses.

French Sanofi Vaccine

The cost of a potential vaccine dose is less than 10 euros.

The vaccine is in the United States

Moderna has priced its experimental vaccine at $ 37 per dose

Pfizer and its partner, BioN Tech, have reported sufficient quantities to immunize 50 million Americans.

World Health Organization
The new corona virus

Global Health sets the “logical date” for the launch of the Corona vaccine

Previously

With the increasing frequency of promising news about the expected vaccine against the Corona virus, as more than one party announced that it is close to its production, the World Health Organization is still cautious in optimism about this matter that the world has been waiting for months … a warning confirmed by the Director-General of the organization, declaring that no A widely effective vaccine is expected “before the middle of next year”.

This announcement appears relatively disappointing after the increase in expectations and announcements about the provision of the vaccine before the end of the year, but there are many challenges facing the process of manufacturing a safe and effective vaccine, the most important of which are those related to ensuring the safety of its use among humans, as the vaccine may be effective among animals, but it is not It prevents infection in humans, as happened with a number of SARS vaccines.

In addition to the need to enable the vaccine to provide long-term protection for individuals, as it turns out, the Corona virus can infect the same person a few months after the first infection.

One of the other most important challenges facing the Corona vaccine is the possibility of protecting people from the older age groups, which are the most vulnerable groups in the face of the virus, which are usually the least responsive to vaccines.

In order for the vaccine to prove its effectiveness and safety, it must pass the animal testing phase first, which are tests that follow strict laboratory guidelines and usually take between three and six months.

After that, the clinical testing stage begins, which is in 3 stages, where the first stage is devoted to assessing the safety of the vaccine in terms of use in humans.

According to “Sky News” during the second stage, the vaccine composition and doses are approved in order to ensure its effectiveness.

As for the third stage, it is necessary to ensure the safety and efficacy of the vaccine on a larger group of individuals.

Steps that global laboratories are close to achieving in their battle with the Corona virus, today there are 9 vaccines around the world that have entered the final stage of testing, while the world remains waiting.

As for the most prominent vaccines that are currently being worked on, we review them as follows:

Russian vaccine

Researchers say that “Sputnik-V” gives initial encouraging results .. It made an immune response and did not leave side effects.

Chinese vaccine

“Sinopharma” will be ready for public use by the end of 2020, according to company statements, and it will be available at a cost of $ 144 for the two doses.

French Sanofi Vaccine

The cost of a potential vaccine dose is less than 10 euros.

The vaccine is in the United States

Moderna has priced its experimental vaccine at $ 37 per dose

Pfizer and its partner, BioN Tech, have reported sufficient quantities to immunize 50 million Americans.

07 September 2020 – 19 Muharram 1442

08:52 AM


With the increasing frequency of promising news about the expected vaccine for the virus

With the increasing frequency of promising news about the expected vaccine against the Corona virus, as more than one party announced that it is close to its production, the World Health Organization is still cautious in optimism about this matter that the world has been waiting for months … a warning confirmed by the Director-General of the organization, declaring that no A widely effective vaccine is expected “before the middle of next year”.

This announcement appears relatively disappointing after the increase in expectations and announcements about the provision of the vaccine before the end of the year, but there are many challenges facing the process of manufacturing a safe and effective vaccine, the most important of which are those related to ensuring the safety of its use among humans, as the vaccine may be effective among animals, but it is not It prevents infection in humans, as happened with a number of SARS vaccines.

In addition to the need to enable the vaccine to provide long-term protection for individuals, as it turns out, the Corona virus can infect the same person a few months after the first infection.

One of the other most important challenges facing the Corona vaccine, is the possibility of protecting people from the older age groups, which are the most vulnerable groups in the face of the virus, which are usually the least responsive to vaccines.

In order for the vaccine to prove its effectiveness and safety, it must pass the animal testing phase first, which are tests that follow strict laboratory guidelines and usually take between three and six months.

After that, the clinical testing stage begins, which is in 3 stages, where the first stage is devoted to assessing the safety of the vaccine in terms of use in humans.

According to “Sky News”, during the second stage, the vaccine composition and doses are approved in order to ensure its effectiveness.

As for the third stage, it is necessary to ensure the safety and effectiveness of the vaccine on a larger group of individuals.

Steps that global laboratories are close to achieving in their battle with the Corona virus, today there are 9 vaccines around the world that have entered the final stage of testing, while the world remains waiting.

As for the most prominent vaccines that are currently being worked on, we review them as follows:

Russian vaccine

Researchers say that “Sputnik-V” gives initial encouraging results .. It made an immune response and did not leave side effects.

Chinese vaccine

“Sinopharma” will be ready for public use by the end of 2020, according to company statements, and it will be available at a cost of $ 144 for the two doses.

French Sanofi Vaccine

The cost of a potential vaccine dose is less than 10 euros.

The vaccine is in the United States

Moderna has priced its experimental vaccine at $ 37 per dose

Pfizer and its partner, BioN Tech, have reported sufficient quantities to immunize 50 million Americans.





LEAVE A REPLY

Please enter your comment!
Please enter your name here